Drugs / AS1409
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00625768 | Jan 2008 → Apr 2009 | metastatic melanoma, renal cell carcinoma | Antisoma Research | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AS1409 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00625768 ↗ |
| Known as | HUBC1-HUIL12 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109413 ↗ |
| Route | Intravenous | “weekly infusional AS1409” PMID 21447719 ↗ Mar 2011 |
| Target | FN1 | “Fibronectin binding agent” CHEMBL2109413 ↗ |